1	p70(s6k)	p70(s6k)	_	_	_	_	_	_	_
2	integrates	integrate	_	_	_	_	_	_	_
3	phosphatidylinositol	phosphatidylinositol	_	_	_	_	_	_	_
4	3-kinase	3-kinase	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	rapamycin-regulated	rapamycin-regulated	_	_	_	_	_	_	_
7	signals	signal	_	_	_	_	_	_	_
8	for	for	_	_	_	_	_	_	_
9	E2F	E2F	_	_	_	_	_	_	_
10	regulation	regulation	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	lymphocytes	lymphocyte	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	T	t	_	_	_	_	_	_	_
3	lymphocytes	lymphocyte	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	hematopoietic	hematopoietic	_	_	_	_	_	_	_
7	cytokine	cytokine	_	_	_	_	_	_	_
8	interleukin-2	interleukin-2	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	IL-2	il-2	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	uses	use	_	_	_	_	_	_	_
13	phosphatidylinositol	phosphatidylinositol	_	_	_	_	_	_	_
14	3-kinase	3-kinase	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	PI	PI	_	_	_	_	_	_	_
17	3-kinase)-induced	3-kinase)-induced	_	_	_	_	_	_	_
18	signaling	signaling	_	_	_	_	_	_	_
19	pathways	pathway	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	regulate	regulate	_	_	_	_	_	_	_
22	E2F	E2F	_	_	_	_	_	_	_
23	transcriptional	transcriptional	_	_	_	_	_	_	_
24	activity	activity	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	a	a	_	_	_	_	_	_	_
27	critical	critical	_	_	_	_	_	_	_
28	cell	cell	_	_	_	_	_	_	_
29	cycle	cycle	_	_	_	_	_	_	_
30	checkpoint	checkpoint	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	PI	pi	_	_	_	_	_	_	_
2	3-kinase	3-kinase	_	_	_	_	_	_	_
3	also	also	_	_	_	_	_	_	_
4	regulates	regulate	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	activity	activity	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	p70(s6k)	p70(s6k)	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	40S	40s	_	_	_	_	_	_	_
12	ribosomal	ribosomal	_	_	_	_	_	_	_
13	protein	protein	_	_	_	_	_	_	_
14	S6	S6	_	_	_	_	_	_	_
15	kinase	kinase	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	response	response	_	_	_	_	_	_	_
19	that	that	_	_	_	_	_	_	_
20	is	be	_	_	_	_	_	_	_
21	abrogated	abrogate	_	_	_	_	_	_	_
22	by	by	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	macrolide	macrolide	_	_	_	_	_	_	_
25	rapamycin	rapamycin	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	immunosuppressive	immunosuppressive	_	_	_	_	_	_	_
3	drug	drug	_	_	_	_	_	_	_
4	is	be	_	_	_	_	_	_	_
5	known	know	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	prevent	prevent	_	_	_	_	_	_	_
8	T-cell	t-cell	_	_	_	_	_	_	_
9	proliferation	proliferation	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	but	but	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	precise	precise	_	_	_	_	_	_	_
14	point	point	_	_	_	_	_	_	_
15	at	at	_	_	_	_	_	_	_
16	which	which	_	_	_	_	_	_	_
17	rapamycin	rapamycin	_	_	_	_	_	_	_
18	regulates	regulate	_	_	_	_	_	_	_
19	T-cell	t-cell	_	_	_	_	_	_	_
20	cycle	cycle	_	_	_	_	_	_	_
21	progression	progression	_	_	_	_	_	_	_
22	has	have	_	_	_	_	_	_	_
23	yet	yet	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	be	be	_	_	_	_	_	_	_
26	elucidated	elucidate	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Moreover	moreover	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	effects	effect	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	rapamycin	rapamycin	_	_	_	_	_	_	_
7	on	on	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	role	role	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	p70(s6k)	p70(s6k)	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	IL-2	IL-2	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	PI	PI	_	_	_	_	_	_	_
19	3-kinase	3-kinase	_	_	_	_	_	_	_
20	activation	activation	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	E2Fs	e2f	_	_	_	_	_	_	_
23	have	have	_	_	_	_	_	_	_
24	not	not	_	_	_	_	_	_	_
25	been	be	_	_	_	_	_	_	_
26	characterized	characterize	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	present	present	_	_	_	_	_	_	_
3	results	result	_	_	_	_	_	_	_
4	show	show	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	IL-2-	IL-2-	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	PI	PI	_	_	_	_	_	_	_
9	3-kinase-induced	3-kinase-induced	_	_	_	_	_	_	_
10	pathways	pathway	_	_	_	_	_	_	_
11	for	for	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	regulation	regulation	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	E2F	E2F	_	_	_	_	_	_	_
16	transcriptional	transcriptional	_	_	_	_	_	_	_
17	activity	activity	_	_	_	_	_	_	_
18	include	include	_	_	_	_	_	_	_
19	both	both	_	_	_	_	_	_	_
20	rapamycin-resistant	rapamycin-resistant	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	rapamycin-sensitive	rapamycin-sensitive	_	_	_	_	_	_	_
23	components	component	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Expression	expression	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	rapamycin-resistant	rapamycin-resistant	_	_	_	_	_	_	_
5	mutant	mutant	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	p70(s6k)	p70(s6k)	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	T	t	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	could	could	_	_	_	_	_	_	_
12	restore	restore	_	_	_	_	_	_	_
13	rapamycin-suppressed	rapamycin-suppressed	_	_	_	_	_	_	_
14	E2F	e2f	_	_	_	_	_	_	_
15	responses	response	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	rapamycin-controlled	rapamycin-controlled	_	_	_	_	_	_	_
5	processes	process	_	_	_	_	_	_	_
6	involved	involve	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	E2F	E2F	_	_	_	_	_	_	_
9	regulation	regulation	_	_	_	_	_	_	_
10	appear	appear	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	be	be	_	_	_	_	_	_	_
13	mediated	mediate	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	p70(s6k)	p70(s6k)	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	rapamycin-resistant	rapamycin-resistant	_	_	_	_	_	_	_
5	p70(s6k)	p70(s6k)	_	_	_	_	_	_	_
6	could	could	_	_	_	_	_	_	_
7	not	not	_	_	_	_	_	_	_
8	rescue	rescue	_	_	_	_	_	_	_
9	rapamycin	rapamycin	_	_	_	_	_	_	_
10	inhibition	inhibition	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	T-cell	t-cell	_	_	_	_	_	_	_
13	cycle	cycle	_	_	_	_	_	_	_
14	entry	entry	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	consistent	consistent	_	_	_	_	_	_	_
17	with	with	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	involvement	involvement	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	additional	additional	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	rapamycin-sensitive	rapamycin-sensitive	_	_	_	_	_	_	_
24	pathways	pathway	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	control	control	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	T-cell	t-cell	_	_	_	_	_	_	_
30	cycle	cycle	_	_	_	_	_	_	_
31	progression	progression	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	present	present	_	_	_	_	_	_	_
3	results	result	_	_	_	_	_	_	_
4	thus	thus	_	_	_	_	_	_	_
5	show	show	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	p70(s6k)	p70(s6k)	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	able	able	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	regulate	regulate	_	_	_	_	_	_	_
12	E2F	E2F	_	_	_	_	_	_	_
13	transcriptional	transcriptional	_	_	_	_	_	_	_
14	activity	activity	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	provide	provide	_	_	_	_	_	_	_
17	direct	direct	_	_	_	_	_	_	_
18	evidence	evidence	_	_	_	_	_	_	_
19	for	for	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	first	first	_	_	_	_	_	_	_
22	time	time	_	_	_	_	_	_	_
23	for	for	_	_	_	_	_	_	_
24	a	a	_	_	_	_	_	_	_
25	link	link	_	_	_	_	_	_	_
26	between	between	_	_	_	_	_	_	_
27	IL-2	il-2	_	_	_	_	_	_	_
28	receptors	receptor	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	PI	PI	_	_	_	_	_	_	_
31	3-kinase	3-kinase	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	and	and	_	_	_	_	_	_	_
34	p70(s6k)	p70(s6k)	_	_	_	_	_	_	_
35	that	that	_	_	_	_	_	_	_
36	regulates	regulate	_	_	_	_	_	_	_
37	a	a	_	_	_	_	_	_	_
38	crucial	crucial	_	_	_	_	_	_	_
39	G1	g1	_	_	_	_	_	_	_
40	checkpoint	checkpoint	_	_	_	_	_	_	_
41	in	in	_	_	_	_	_	_	_
42	T	t	_	_	_	_	_	_	_
43	lymphocytes	lymphocyte	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

